BACKGROUND: Concerted efforts have been directed toward recruitment of community rather than replacement donors in Brazil. Time trends and demographic correlates of human immunodeficiency (HIV) prevalence and incidence among first-time (FT) donors in Brazil were examined by donation type. HIV residual risk from FT-donor transfusions, and projected yield of p24 antigen and nucleic acid test (NAT) screening were estimated. STUDY DESIGN AND METHODS: HIV prevalence data and seroreactive specimens were obtained at Fundação Pró-Sangue/Hemocentro-de-São Paulo from 1995 to 2001. To estimate incidence, confirmed-positive samples from July 1998 through December 2001 were tested with a less-sensitive (detuned) enzyme immunoassay to detect recent seroconversions. Incidence data were used to estimate residual risk and p24 and NAT yield based on published window periods (WPs). RESULTS: HIV prevalence was 22 percent higher among the FT community donors than replacement donors (19.6 vs. 16.1 per 10,000; p < 0.01) and 48 percent higher among men than women (19.1 vs. 12.9; p < 0.01). In the multivariable logistic regression, both variables remained significant predictors of HIV prevalence. HIV prevalence decreased from 20.4 (1995) to 13.1 per 10,000 FT donations (2001). HIV incidence was 2.7 per 10,000 person-years. The estimated rate of infected antibody-negative donations was 14.9 per 1,000,000 units (95% confidence interval, 9.8-20.0). It was estimated that addition of p24 antigen, minipool NAT, and individual-donation NAT assays would detect 3.9 (2.0-5.8), 8.3 (5.3-11.3), and 10.8 (7.1-14.5) WP units per 1,000,000 FT donations, respectively. CONCLUSION: HIV incidence and residual transfusion risk estimates are approximately 10 times higher in Brazil FT donors compared to US and European FT donors. Community FT donors had higher HIV prevalence than replacement FT donors. The yield of p24 antigen or RNA screening will be low in Brazilian donors, but substantially higher than in US donors.
BACKGROUND: Concerted efforts have been directed toward recruitment of community rather than replacement donors in Brazil. Time trends and demographic correlates of humanimmunodeficiency (HIV) prevalence and incidence among first-time (FT) donors in Brazil were examined by donation type. HIV residual risk from FT-donor transfusions, and projected yield of p24 antigen and nucleic acid test (NAT) screening were estimated. STUDY DESIGN AND METHODS: HIV prevalence data and seroreactive specimens were obtained at Fundação Pró-Sangue/Hemocentro-de-São Paulo from 1995 to 2001. To estimate incidence, confirmed-positive samples from July 1998 through December 2001 were tested with a less-sensitive (detuned) enzyme immunoassay to detect recent seroconversions. Incidence data were used to estimate residual risk and p24 and NAT yield based on published window periods (WPs). RESULTS: HIV prevalence was 22 percent higher among the FT community donors than replacement donors (19.6 vs. 16.1 per 10,000; p < 0.01) and 48 percent higher among men than women (19.1 vs. 12.9; p < 0.01). In the multivariable logistic regression, both variables remained significant predictors of HIV prevalence. HIV prevalence decreased from 20.4 (1995) to 13.1 per 10,000 FT donations (2001). HIV incidence was 2.7 per 10,000 person-years. The estimated rate of infected antibody-negative donations was 14.9 per 1,000,000 units (95% confidence interval, 9.8-20.0). It was estimated that addition of p24 antigen, minipool NAT, and individual-donation NAT assays would detect 3.9 (2.0-5.8), 8.3 (5.3-11.3), and 10.8 (7.1-14.5) WP units per 1,000,000 FT donations, respectively. CONCLUSION: HIV incidence and residual transfusion risk estimates are approximately 10 times higher in Brazil FT donors compared to US and European FT donors. Community FT donors had higher HIV prevalence than replacement FT donors. The yield of p24 antigen or RNA screening will be low in Brazilian donors, but substantially higher than in US donors.
Authors: Surender Khurana; James Needham; Susan Park; Bonnie Mathieson; Michael P Busch; George Nemo; Phillipe Nyambi; Susan Zolla-Pazner; Suman Laal; Joseph Mulenga; Elwyn Chomba; Eric Hunter; Susan Allen; James McIntyre; Indira Hewlett; Sherwin Lee; Shixing Tang; Elliot Cowan; Chris Beyrer; Marcus Altfeld; Xu G Yu; Anatole Tounkara; Ousmane Koita; Anatoli Kamali; Nga Nguyen; Barney S Graham; Deborah Todd; Peter Mugenyi; Omu Anzala; Eduard Sanders; Nzeera Ketter; Patricia Fast; Hana Golding Journal: J Acquir Immune Defic Syndr Date: 2006-11-01 Impact factor: 3.731
Authors: Giuseppina Maria Patavino; Cesar de Almeida-Neto; Jing Liu; David J Wright; Alfredo Mendrone-Junior; Maria Inês Lopes Ferreira; Anna Bárbara de Freitas Carneiro; Brian Custer; João Eduardo Ferreira; Michael P Busch; Ester Cerdeira Sabino Journal: Transfusion Date: 2011-07-14 Impact factor: 3.157
Authors: Thelma T Goncalez; Paula F Blatyta; Fernanda M Santos; Sandra Montebello; Sandra P D Esposti; Fatima N Hangai; Nanci A Salles; Alfredo Mendrone; Hong-Ha M Truong; Ester C Sabino; Willi McFarland Journal: Transfusion Date: 2015-02-03 Impact factor: 3.157
Authors: Jaime Soria; Marta Bull; Caroline Mitchell; Alberto La Rosa; Sandra Dross; Kelli Kraft; Robert Coombs; Eduardo Ticona; Lisa Frenkel Journal: AIDS Res Hum Retroviruses Date: 2011-08-05 Impact factor: 2.205
Authors: Anna Bárbara Carneiro-Proietti; Ester C Sabino; Divaldo Sampaio; Fernando A Proietti; Thelma T Gonçalez; Cláudia D L Oliveira; João E Ferreira; Jing Liu; Brian Custer; George B Schreiber; Edward L Murphy; Michael P Busch Journal: Transfusion Date: 2009-12-10 Impact factor: 3.157
Authors: Thelma T Gonçalez; Ester C Sabino; Nanci Alves Salles; Cesar de Almeida-Neto; Alfredo Mendrone; Pedro E Dorlhiac-Laccer; Jing Liu; Edward L Murphy; George B Schreiber Journal: Transfusion Date: 2009-12-09 Impact factor: 3.157
Authors: Thelma T Goncalez; Ester C Sabino; Sanny Chen; Nanci Alves Salles; Dalton A F Chamone; Willi McFarland; Edward L Murphy Journal: AIDS Behav Date: 2008-04-04
Authors: Thelma T Gonçalez; Ester C Sabino; Karen S Schlumpf; David J Wright; Alfredo Mendrone; Maria Lopes; Silvana Leão; Carolina Miranda; Ligia Capuani; Anna Barbara F Carneiro-Proietti; Fernando Basques; João E Ferreira; Michael Busch; Brian Custer Journal: Transfusion Date: 2012-07-31 Impact factor: 3.157